News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Kraig Biocraft Laboratories Announces Intention to Diversify and Expand its Production Base
May 13, 2024
·
2 min read
Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
May 13, 2024
·
4 min read
Drug Development
Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
May 10, 2024
·
10 min read
Scryb Announces Private Placement Extension
May 9, 2024
·
3 min read
Drug Development
Maxwell Biosciences Enters Second CRADA with USAMRIID to Test Claromer Compounds as Potential Therapeutics for Viral and Bacterial Pathogens
May 8, 2024
·
3 min read
Neural Therapeutics Receives Conditional Approval to Listing on the CSE and Announces Concurrent Financing
May 8, 2024
·
8 min read
Kiora Pharmaceuticals to Present at The Citizens JMP Life Sciences Conference
May 8, 2024
·
1 min read
Phizzle Introduces First Data Transformation Engine for BioPharma/GMP Use; Makes it Possible to Harmonize Data into any LIMs from any Instrument
May 7, 2024
·
1 min read
NervGen Files Management Information Circular and Announces Board of Directors Transition
May 7, 2024
·
5 min read
Biotech Beach
Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
May 6, 2024
·
7 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us